http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-26036-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd16707ea82e7e0ab85dd7640c3c443c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34 |
| filingDate | 2007-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c691f61fb5008e79795c26a53bb6dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9346e86475738f89731a37e80c7c4942 |
| publicationDate | 2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-26036-U |
| titleOfInvention | Method for treatment of localized forms of breast dyshormonal hyperplasia |
| abstract | A method for treatment of localized forms of breast dyshormonal hyperplasia comprises the antiestrogen therapy. Fareston is used as antiestrogen at a daily dose of 20 mg (on permanent basis) and progestins are used at the second half of the menstrual cycle: Dufaston at a daily dose of 10 mg and gel application of Progestoegel to both breasts once a day. The treatment course lasts 6 months. |
| priorityDate | 2007-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.